Dynavax Technologies reported $67.3M in Stock for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Adma Biologics ADMA:US $ 114.12M 14.42M
Alexion Pharmaceuticals ALXN:US $ 803.9M 28.2M
Amgen AMGN:US $ 4152M 37M
Biogen BIIB:US $ 1347.9M 93.1M
Biomarin Pharmaceutical BMRN:US $ 749.41M 38.43M
Bristol Myers Squibb BMY:US $ 2163M 26M
Dynavax Technologies DVAX:US $ 67.3M 19.15M
Gilead Sciences GILD:US $ 2797M 191M
Nektar Therapeutics NKTR:US $ 15.33M 0.71M
Neurocrine Biosciences NBIX:US $ 25.5M 2.8M
Novartis NOVN:VX SF 6885M 226M
Regeneron Pharmaceuticals REGN:US $ 1550.1M 433.8M
Vertex Pharmaceuticals VRTX:US $ 333.46M 11.84M